1.
Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for
Study
1.2.3.
Key Market
Segmentations
2.
Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Antimicrobial Resistance
Surveillance Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Solution
(Diagnostic kits, Diagnostic systems, Surveillance software, Services)
5.2.2.
By Application
(Clinical Diagnostics, Public Health Surveillance, Other Applications)
5.2.3.
By End User
(Hospitals & Clinics, Research & Academic Institutes, Others)
5.2.4.
By Region
5.2.5.
By Company (2023)
5.3. Market Map
6.
North America Antimicrobial
Resistance Surveillance Market Outlook
6.1.
Market Size &
Forecast
6.1.1.
By Value
6.2.
Market Share &
Forecast
6.2.1.
By Solution
6.2.2.
By Application
6.2.3.
By End User
6.2.4.
By Country
6.3. North America: Country Analysis
6.3.1.
United States Antimicrobial
Resistance Surveillance Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Solution
6.3.1.2.2.
By Application
6.3.1.2.3.
By End User
6.3.2.
Canada Antimicrobial
Resistance Surveillance Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Solution
6.3.2.2.2.
By Application
6.3.2.2.3.
By End User
6.3.3.
Mexico Antimicrobial
Resistance Surveillance Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Solution
6.3.3.2.2.
By Application
6.3.3.2.3.
By End User
7.
Europe Antimicrobial
Resistance Surveillance Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Solution
7.2.2.
By Application
7.2.3.
By End User
7.2.4.
By Country
7.3. Europe: Country Analysis
7.3.1.
Germany Antimicrobial
Resistance Surveillance Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Solution
7.3.1.2.2.
By Application
7.3.1.2.3.
By End User
7.3.2.
United Kingdom Antimicrobial
Resistance Surveillance Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Solution
7.3.2.2.2.
By Application
7.3.2.2.3.
By End User
7.3.3.
Italy Antimicrobial
Resistance Surveillance Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Solution
7.3.3.2.2.
By Application
7.3.3.2.3.
By End User
7.3.4.
France Antimicrobial
Resistance Surveillance Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Solution
7.3.4.2.2.
By Application
7.3.4.2.3.
By End User
7.3.5.
Spain Antimicrobial
Resistance Surveillance Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Solution
7.3.5.2.2.
By Application
7.3.5.2.3.
By End User
8.
Asia-Pacific Antimicrobial
Resistance Surveillance Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Solution
8.2.2.
By Application
8.2.3.
By End User
8.2.4.
By Country
8.3. Asia-Pacific: Country Analysis
8.3.1.
China Antimicrobial
Resistance Surveillance Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Solution
8.3.1.2.2.
By Application
8.3.1.2.3.
By End User
8.3.2.
India Antimicrobial
Resistance Surveillance Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Solution
8.3.2.2.2.
By Application
8.3.2.2.3.
By End User
8.3.3.
Japan Antimicrobial
Resistance Surveillance Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Solution
8.3.3.2.2.
By Application
8.3.3.2.3.
By End User
8.3.4.
South Korea Antimicrobial
Resistance Surveillance Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Solution
8.3.4.2.2.
By Application
8.3.4.2.3.
By End User
8.3.5.
Australia Antimicrobial
Resistance Surveillance Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Solution
8.3.5.2.2.
By Application
8.3.5.2.3.
By End User
9.
South America Antimicrobial
Resistance Surveillance Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Solution
9.2.2.
By Application
9.2.3.
By End User
9.2.4.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Antimicrobial
Resistance Surveillance Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Solution
9.3.1.2.2.
By Application
9.3.1.2.3.
By End User
9.3.2.
Argentina Antimicrobial
Resistance Surveillance Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Solution
9.3.2.2.2.
By Application
9.3.2.2.3.
By End User
9.3.3.
Colombia Antimicrobial
Resistance Surveillance Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Solution
9.3.3.2.2.
By Application
9.3.3.2.3.
By End User
10.
Middle East and
Africa Antimicrobial Resistance Surveillance Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1.
By Solution
10.2.2.
By Application
10.2.3.
By End User
10.2.4. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Antimicrobial Resistance Surveillance
Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Solution
10.3.1.2.2.
By Application
10.3.1.2.3.
By End User
10.3.2. Saudi Arabia Antimicrobial Resistance Surveillance
Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Solution
10.3.2.2.2.
By Application
10.3.2.2.3.
By End User
10.3.3. UAE Antimicrobial Resistance Surveillance
Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share &
Forecast
10.3.3.2.1.
By Solution
10.3.3.2.2.
By Application
10.3.3.2.3.
By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1.
Merger &
Acquisition (If Any)
12.2.
Product Launches (If
Any)
12.3.
Recent Developments
13.
Porter’s Five Forces Analysis
13.1.
Competition in the Industry
13.2.
Potential of New Entrants
13.3.
Power of Suppliers
13.4.
Power of Customers
13.5.
Threat of Substitute Product
14. Competitive Landscape
14.1.
Luminex Corporation (DiaSorin)
14.1.1. Business Overview
14.1.2. Company Snapshot
14.1.3. Products & Services
14.1.4. Financials (As Reported)
14.1.5. Recent Developments
14.1.6. Key Personnel Details
14.1.7. SWOT Analysis
14.2.
Thermo Fisher Scientific Inc
14.3.
Accelerate Diagnostics, Inc.
14.4.
Liofilchem S.r.I.
14.5.
Becton, Dickinson and Company
14.6.
Biomerieux Inc.
14.7.
Bruker Corp.
14.8.
Danaher Corporation
14.9.
Merck KgaA
14.10.Abbott Laboratories Inc.
15.
Strategic Recommendations
16.
About Us & Disclaimer